PositiveID (PSID) to Present at International Security and Defense Conference

DELRAY BEACH, Fla., Sept. 6, 2011 (GLOBE NEWSWIRE) -- PositiveID Corporation (“PositiveID” or “Company”) (OTCBB:PSID), a developer of medical technologies for diabetes management, clinical diagnostics and bio-threat detection, announced today that M. Allen Northrup, Ph.D., CEO of the Company’s MicroFluidic Systems (“MFS”) subsidiary, will present at the SPIE Security + Defense Exhibition on September 19, 2011, at the Clarion Congress Hotel in Prague. Northrup will present at the Sensing and Screening II session of the conference, number 8189A Optics and Photonics for Counterterrorism and Crime Fighting. The SPIE Exhibition showcases the latest technology innovations and future applications, specializing in detection, imaging, lasers, and a multitude of supporting mechanisms and devices. SPIE Security + Defense is the leading defense and security event in Europe.

MORE ON THIS TOPIC